Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study
Autor: | Leerink, J.M., Feijen, E.L.A.M., Pal, H.J.H. van der, Kok, W.E.M., Mavinkurve-Groothuis, A.M.C., Kapusta, L., Pinto, Y.M., Maas, A.H.E.M., Bellersen, L., Teske, A.J., Ronckers, C.M., Louwerens, M., Dalen, E.C. van, Dulmen-den Broeder, E. van, Batenburg, L., Heiden-van der Loo, M. van der, Heuvel-Eibrink, M.M. van den, Leeuwen, F.E. van, Vries, A.C.H. de, Weijers, G., Korte, C.L. de, Loonen, J.J., Neggers, S.J.C.M.M., Versluys, A.B.B., Tissing, W.J.E., Kremer, L.C.M., Grootenhuis, M.A., Hartogh, J.G. den, Santen, H. van, LATER Study Grp |
---|---|
Přispěvatelé: | Guided Treatment in Optimal Selected Cancer Patients (GUTS), Pediatrics, Internal Medicine, Pediatric surgery, CCA - Cancer Treatment and quality of life, Amsterdam Reproduction & Development (AR&D) |
Rok vydání: | 2020 |
Předmět: |
Male
Cross-sectional study Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] Apoptosis ADULT SURVIVORS 030204 cardiovascular system & hematology Electrocardiography Ventricular Dysfunction Left 0302 clinical medicine Cancer Survivors Risk Factors Neoplasms Myocytes Cardiac 030212 general & internal medicine Child AMERICAN SOCIETY Subclinical infection Netherlands medicine.diagnostic_test Ventricular Remodeling DIASTOLIC DYSFUNCTION Cardiovascular physiology Echocardiography CARDIOVASCULAR-DISEASE Child Preschool Cardiology HEART-FAILURE Female Cardiology and Cardiovascular Medicine medicine.medical_specialty Adolescent Heart Diseases Lower risk Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] EJECTION FRACTION 03 medical and health sciences All institutes and research themes of the Radboud University Medical Center SDG 3 - Good Health and Well-being Internal medicine medicine Journal Article Humans Ventricular remodeling Heart Failure Inflammation EUROPEAN ASSOCIATION business.industry MORTALITY fungi Infant Newborn Cancer Infant 5-YEAR SURVIVORS medicine.disease Oxidative Stress Cross-Sectional Studies Early Diagnosis Heart failure business FOLLOW-UP Biomarkers |
Zdroj: | American Heart Journal, 219, 89-98 American Heart Journal, 219, 89. Mosby Inc. Leerink, J M, Feijen, E L A M, van der Pal, H J H, Kok, W E M, Mavinkurve-Groothuis, A M C, Kapusta, L, Pinto, Y M, Maas, A H E M, Bellersen, L, Teske, A J, Ronckers, C M, Louwerens, M, van Dalen, E C, van Dulmen-den Broeder, E, Batenburg, L, van der Heiden-van der Loo, M, van den Heuvel-Eibrink, M M, van Leeuwen, F E, de Vries, A C H, Weijers, G, de Korte, C L, Loonen, J J, Neggers, S J C M M, Versluys, A B B, Tissing, W J E, Kremer, L C M & on behalf of the LATER Study Group 2020, ' Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors : Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study ', American Heart Journal, vol. 219, pp. 89-98 . https://doi.org/10.1016/j.ahj.2019.10.010 American Heart Journal, 219, 89-98. MOSBY-ELSEVIER American Heart Journal, 219, 89-98. Mosby Inc. American Heart Journal, 219, pp. 89-98 |
ISSN: | 0002-8703 |
DOI: | 10.1016/j.ahj.2019.10.010 |
Popis: | Background Cancer therapy-related cardiac dysfunction and heart failure are major problems in long-term childhood cancer survivors (CCS). We hypothesize that assessment of more sensitive echo- and electrocardiographic measurements, and/or biomarkers will allow for improved recognition of patients with cardiac dysfunction before heart failure develops, and may also identify patients at lower risk for heart failure.Objective To describe the methodology of the Dutch LATER cardiology study (LATER CARD).Methods The LATER CARD study is a cross-sectional study in long-term CCS treated with (potentially) cardiotoxic cancer therapies and sibling controls. We will evaluate 1) the prevalence and associated (treatment related) risk factors of subclinical cardiac dysfunction in CCS compared to sibling controls and 2) the diagnostic value of echocardiography including myocardial strain and diastolic function parameters, blood biomarkers for cardiomyocyte apoptosis, oxidative stress, cardiac remodeling and inflammation and ECG or combinations of them in the surveillance for cancer therapy-related cardiac dysfunction. From 2017 to 2020 we expect to include 1900 CCS and 500 siblings.Conclusions The LATER CARD study will provide knowledge on different surveillance modalities for detection of cardiac dysfunction in long-term CCS at risk for heart failure. The results of the study will enable us to improve long-term follow-up surveillance guidelines for CCS at risk for heart failure. |
Databáze: | OpenAIRE |
Externí odkaz: |